Tango Therapeutics Inc (TNGX)

Operating Cash Flow (Statement)

-$38.87M

Quarterly · Period ending: · USD

TNGX logo

TNGX Operating Cash Flow (Statement)

Latest reported-$38.87M
TNGX Quarterly Cash from Operations (-$12.13M → -$38.87M)
High-resolution chart · PNG

TNGX operating cash flow (statement) history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Tango Therapeutics Inc Operating Cash Flow (Statement) — Quarterly (USD)
Period endingOperating Cash Flow (Statement) (USD)
-38,866,000
-44,360,000
-29,718,000
-30,952,000
-36,519,000
-41,697,000
-36,647,000
-33,390,000
-23,607,000
-37,857,000
-27,467,000
-31,135,000
-24,473,000
-34,907,000
-28,266,000
-19,611,000
-31,538,000
-29,665,000
-16,902,000
-21,494,000
-7,518,000
-13,613,000
-18,062,000
111,259,000
-10,995,000
-12,128,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.